Cargando…

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

The parasite Trypanosoma cruzi is the causative agent of Chagas disease, a potentially life-threatening infection that represents a major health problem in Latin America. Several characteristics of this protozoan contribute to the lack of an effective vaccine, among them: its silent invasion mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez Alberti, Andrés, Bivona, Augusto E., Cerny, Natacha, Schulze, Kai, Weißmann, Sebastian, Ebensen, Thomas, Morales, Celina, Padilla, Angel M., Cazorla, Silvia I., Tarleton, Rick L., Guzmán, Carlos A., Malchiodi, Emilio L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604744/ https://www.ncbi.nlm.nih.gov/pubmed/29263868 http://dx.doi.org/10.1038/s41541-017-0010-z

Ejemplares similares

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
por: Sanchez Alberti, Andrés, et al.
Publicado: (2020)

Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine
por: Bivona, Augusto E., et al.
Publicado: (2018)

Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
por: Cerny, Natacha, et al.
Publicado: (2020)

Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis
por: Sülsen, Valeria P., et al.
Publicado: (2019)

In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection
por: Sánchez Alberti, Andrés, et al.
Publicado: (2021)

Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi
por: Matos, Marina N., et al.
Publicado: (2017)

Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.
por: Laurella, Laura C., et al.
Publicado: (2017)

Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti-Trypanosoma cruzi Activity
por: Beer, María F., et al.
Publicado: (2022)

Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
por: Sánchez-Valdéz, Fernando J, et al.
Publicado: (2018)

Chromosome level assembly of the hybrid Trypanosoma cruzi genome
por: Weatherly, D Brent, et al.
Publicado: (2009)

Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi
por: Xu, Dan, et al.
Publicado: (2009)

Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection
por: Bustamante, Juan, et al.
Publicado: (2015)

Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi
por: Weatherly, D. Brent, et al.
Publicado: (2016)

Anti-Trypanosoma cruzi Activity of Extracts from Argentinean Asteraceae Species
por: Selener, Mariana G., et al.
Publicado: (2019)

Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts
por: Padilla, Angel M., et al.
Publicado: (2023)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi
por: Minning, Todd A, et al.
Publicado: (2009)

Identification of Contractile Vacuole Proteins in Trypanosoma cruzi
por: Ulrich, Paul N., et al.
Publicado: (2011)

In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
por: Canavaci, Adriana M. C., et al.
Publicado: (2010)

Knockout of the dhfr-ts Gene in Trypanosoma cruzi Generates Attenuated Parasites Able to Confer Protection against a Virulent Challenge
por: Perez Brandan, Cecilia, et al.
Publicado: (2011)

Inhibition of HIV-1 Replication in Human Monocyte-Derived Macrophages by Parasite Trypanosoma cruzi
por: Andreani, Guadalupe, et al.
Publicado: (2009)

Trypanocidal Activity of Four Sesquiterpene Lactones Isolated from Asteraceae Species
por: Elso, Orlando G., et al.
Publicado: (2020)

High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection
por: Cooley, Gretchen, et al.
Publicado: (2008)

CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi
por: Peng, Duo, et al.
Publicado: (2014)

Anti-Trypanosoma cruzi Properties of Sesquiterpene Lactones Isolated from Stevia spp.: In Vitro and In Silico Studies
por: Borgo, Jimena, et al.
Publicado: (2023)

Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection
por: Antonoglou, María Belén, et al.
Publicado: (2020)

Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection
por: Hartley, Ashley N, et al.
Publicado: (2014)

Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization
por: Minning, Todd A, et al.
Publicado: (2011)

Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection
por: Pack, Angela D., et al.
Publicado: (2018)

A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection
por: Bayão, Taciana de Souza, et al.
Publicado: (2020)

A Semantic Problem Solving Environment for Integrative Parasite Research: Identification of Intervention Targets for Trypanosoma cruzi
por: Parikh, Priti P., et al.
Publicado: (2012)

Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease
por: Argüello, Rafael J., et al.
Publicado: (2012)

High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA
por: Padilla, Angel M., et al.
Publicado: (2021)

Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure
por: Bustamante, Juan M., et al.
Publicado: (2022)

Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach
por: Diaz-Hernandez, Alejandro, et al.
Publicado: (2022)

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects
por: Castro Eiro, Melisa D., et al.
Publicado: (2017)

CD8(+) T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes
por: Martin, Diana L, et al.
Publicado: (2006)

High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014)

Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses
por: Alvarez, María G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m2fg1iepmclrfkth8im3qbf5tg